Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis
2011 ◽
Vol 47
(12)
◽
pp. 1826-1836
◽
Keyword(s):
Phase Ii
◽